Barclays initiated coverage of Aflac with a rating of Underweight and set a new price target of $96.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $111.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $102.00 | Hold | TD Cowen |
| 9/5/2024 | $96.00 | Underweight | Barclays |
| 1/4/2024 | $76.00 → $78.00 | In-line → Underperform | Evercore ISI |
| 8/18/2023 | $74.00 → $75.00 | Overweight → Equal-Weight | Morgan Stanley |
| 6/5/2023 | $77.00 | Buy | BofA Securities |
| 4/25/2023 | $73.00 | Equal Weight | Wells Fargo |
| 5/24/2022 | $60.00 | Neutral | Citigroup |
11-K - AFLAC INC (0000004977) (Filer)
8-K - AFLAC INC (0000004977) (Filer)
8-K - AFLAC INC (0000004977) (Filer)
4 - AFLAC INC (0000004977) (Issuer)
4 - AFLAC INC (0000004977) (Issuer)
4 - AFLAC INC (0000004977) (Issuer)
4 - AFLAC INC (0000004977) (Issuer)
4 - AFLAC INC (0000004977) (Issuer)
COLUMBUS, Ga., April 30, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE:AFL) today reported its first quarter results. Total revenues were $3.4 billion in the first quarter of 2025, compared with $5.4 billion in the first quarter of 2024, primarily due to net investment losses of $963 million this quarter compared to net investment gains of $951 million in the first quarter of 2024. Net earnings were $29 million, or $0.05 per diluted share, compared with $1.9 billion, or $3.25 per diluted share a year ago. Net earnings in the first quarter of 2025 included net investment losses of $963 million, or $1.76 per diluted share, compared with net investment gains of $951 million, or $1.65 per dilute
COLUMBUS, Ga., April 3, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE:AFL) announced today that it will release first quarter 2025 financial results after the market closes on April 30, 2025. At that time, earnings materials, including the quarterly earnings release and financial supplement, will be available, along with a financial update video from Senior Executive Vice President and Chief Financial Officer Max Brodén, on the company's Investor Relations website, investors.aflac.com. Aflac Incorporated will also webcast a conference call scheduled for 8:00 a.m. (ET) on Thurs
Teams to focus on preventive wellness by addressing physical, emotional and financial toxicity related to a cancer diagnosis COLUMBUS, Ga., Feb. 25, 2025 /PRNewswire/ -- Aflac Incorporated (Aflac), the leading provider of cancer insurance in the United States and Japan, is teaming up with the American Cancer Society (ACS), the leading cancer-fighting organization with a vision of ending cancer as we know it — for everyone. Together, they will shine a light on the ways early cancer detection can support individuals as they navigate the physical, emotional and financial challenges associated with the disease, particularly as data from the most recent (2024) Aflac Wellness Matters Survey found
BMO Capital Markets initiated coverage of Aflac with a rating of Market Perform and set a new price target of $111.00
TD Cowen initiated coverage of Aflac with a rating of Hold and set a new price target of $102.00
Barclays initiated coverage of Aflac with a rating of Underweight and set a new price target of $96.00